Journal
Neuro-Oncology Advances
Publication Date
1-1-2025
Volume
7
Issue
1
First Page
vdaf117
Document Type
Open Access Publication
DOI
10.1093/noajnl/vdaf117
Rights and Permissions
Jian L Campian, Stuart A Grossman, Angela Shaulov Kask, Samuel Kosydar, Roy Strowd, Anna Piotrowski, Justin Tang, Milan G Chheda, John F DiPersio, Dan Schullery, Leonard D’Amico, Serena Desideri, Neeraja Danda, Sara Ferrando-Martinez, Byung Ha Lee, Steven P Fling, Xiaobu Ye, Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma, Neuro-Oncology Advances, Volume 7, Issue 1, January-December 2025, vdaf117, https://doi.org/10.1093/noajnl/vdaf117. https://academic.oup.com/noa/article/7/1/vdaf117/8158267?login=true. © The Author(s) 2025. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Campian, Jian L; Chheda, Milan G; DiPersio, John F; and et al., "Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high-grade glioma." Neuro-Oncology Advances. 7, 1. vdaf117 (2025).
https://digitalcommons.wustl.edu/oa_4/5551
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
